Sleep is Good…

  • Posted by
  • on October 25th, 2006

I wanted my “Sleep is Good” speech to be as powerful as Gordon Gekko’s “Greed is Good” speech in Wall Street.

Go watch today’s Wallstrip show and you decide :) .

I can’t believe they left the cameras rolling on me all night and that is all they heard by the way :) . By the way, where was Ellen? Filming!

Anyone who knows me, knows that I take sleep and the lack thereof, very seriously. I would not wish sleeping problems on but two people in my life. They probably sleep like babies – and smoke and diet on carbs!

Ambien, from drug maker Sanofi, has been a wonder drug for me – so far – and my family. It has helped me get the sleep I need. It is not the largest drug in Sanofi’s engine, but an important part of their successful history.

Pfizer is working hard on a competitive drug and Sepracor has recently launched Lunesta. The market is “gynormousmungous” TM.

Based on the release of Ambien CR, which did not work for me, I am pretty sure that the patent rights of Ambien are coming to an end for the regular ambien.

I still own the stock, have so since June when it moved to an all-time high. I am down nearly 10 percent on the position since purchase. It is a small position and one of many. As always, I will let the stock do what it does until my stop has been breached (close) or it continues back on it’s winning ways.

No matter what happens to Sanofi and Ambien, you can rest assured that the Sleep Industry is a GIANT and your financial attention should be partially focused in this space. Other sleep related stocks include Respironics (RESP), Resmed (RMD), Sepracor (SEPR), and Pfizer (PFE).

Please share with me and the other bloggers any sleep stocks that I might have missed.

The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.

blog comments powered by Disqus